NCT06143813 Precision Treatment of Lumbar Spine Surgery Through Advanced Nerve Root Blockade
| NCT ID | NCT06143813 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Radiculopathy Lumbar |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2023-11-09 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2023-11-09 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall purpose of the study is to investigate whether selective spinal nerve root blocks can improve diagnostics of radiculopathy due to lumbar disc herniation (LDH), foraminal stenosis (FS), and recess stenosis (RS), and hence identify the patients that will benefit from surgical intervention.
Eligibility Criteria
Inclusion Criteria: * Age \>18 years old * Suspected lumbar radiculopathy persistent ≥ 8 weeks * Radiological evidence of lumbar nerve root compression (herniated disc, recess stenosis, foraminal stenosis) Exclusion Criteria: * Prior lumbar spine surgery * Mental illness * Language barrier in Danish * Severe physical co-morbidity * Known allergies to medicine used in the study * Pregnant * Plans to move abroad during the next 12-months
Contact & Investigator
David Kocemba, MD
PRINCIPAL INVESTIGATOR
University of Aarhus
Frequently Asked Questions
Who can join the NCT06143813 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Radiculopathy Lumbar. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06143813 currently recruiting?
Yes, NCT06143813 is actively recruiting participants. Contact the research team at davkoc@rm.dk for enrollment information.
Where is the NCT06143813 trial being conducted?
This trial is being conducted at Aarhus C, Denmark.
Who is sponsoring the NCT06143813 clinical trial?
NCT06143813 is sponsored by University of Aarhus. The principal investigator is David Kocemba, MD at University of Aarhus. The trial plans to enroll 180 participants.